Lihit Lab.,Inc.
Notice of Revision to Consolidated Earnings Guidance for the Fiscal Year Ending February 2027: Second Quarter (Interim) and Full Year
Despite new product launches and increased domestic mass-retail sales, profits are expected to fall short of prior guidance due to rising raw material costs and yen depreciation. Full-year net sales remain at the initial forecast, but operating income, ordinary income, and net income attributable to owners of parent have been revised downward.
Key Figures
- Revised interim net sales: 4,846 million yen
- Interim operating income: 23 million yen
- Full-year net income attributable to owners of parent: 80 million yen
AI要約
Summary of Revisions
Lihit Lab.,Inc. has revised its consolidated earnings guidance for the second quarter of the fiscal year ending February 2027. Net sales for the interim period remain unchanged from the prior guidance, but profit items have significantly declined due to increased production costs from rising raw material prices and the impact of a weaker yen. Interim operating income, ordinary income, interim net income attributable to owners of parent, and interim net income per share have all been revised downward. For the full year, net sales are unchanged, and while measures to improve profit margins in the second half are planned, results are expected to fall short of the initial forecasts.
Outlook and Impact
New product rollouts and increased domestic mass-retail sales are solid, but sustained high raw material prices and yen depreciation may persist. Going forward, the company will continue cost control and price adjustments; nevertheless, the downward revision impact on full-year results for the fiscal year ending February 2027 is expected to continue.
Lihit Lab.,Inc.
Company overview · Stock price · Financial data · All IR
